Bayerische Motoren Werke v ITCiCo Spain (CFI, 9 February 2024)
| Date | 9 February 2024 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Generic application |
| Case number(s) | UPC_CFI_412/2023 |
| Registry reference | App_4285/2024 · ORD_4804/2024 · UPC_CFI_412/2023 |
| Parties | ITCiCo Spain S.L. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 9 February 2024 (UPC_CFI_412/2023), the judge-rapporteur of the Paris Central Division rejected the request by ITCiCo Spain S.L., defendant in the revocation action against EP 2 796 333 brought by Bayerische Motoren Werke Aktiengesellschaft, to extend the time limit for its Defence to 29 February 2024. The order rejects three common justifications (exhibits served late, access to the case management system, illness of the representative) and stresses that an extension must be sought without delay.
Question
Do service of the Statement of claim without its exhibits, delay in obtaining a smart card for the case management system and the illness of the patent attorney justify extending the time limit for the Defence (Rule 9.3 RoP)?
Decision
The judge-rapporteur recalled that extensions lie within a discretion to be exercised with caution and only in justified exceptional cases (paragraphs 10, 11 and 18), the party having to prove an objective impossibility or very great difficulty in meeting the time limit that is not attributable to it or its representative (paragraphs 19 and 20). Postal service (Rule 271 RoP and Article 18 of Regulation (EU) 2020/1784) was valid even without the exhibits, as the Statement of claim set out the subject matter and cause of action with certainty (paragraphs 22 and 23). The access problem was not substantiated, and a representative awaiting access should promptly seek a solution from the Court or the Registry (paragraphs 24 and 25), the alleged illness was not proven (paragraph 26). Finally, a request filed on the last day when its cause was known earlier is contrary to fairness (paragraphs 21, 27 and 28).
Key points for practice
- Practical point: a request to extend must be filed as soon as it becomes foreseeable that the time limit cannot be met, and supported by evidence, difficulties internal to the representative’s firm are not enough.
Provisions applied
- Rules of Procedure
- Rules 9.3, 9.4, 271.4, 333 and 334
- Regulation (EU) 2020/1784
- Art. 18
- Case law cited
- Seoul Viosys v Expert E-Commerce, Düsseldorf Local Division, 20 January 2024, Sanofi-Aventis Deutschland v Amgen, Court of Appeal, 13 October 2023, Paris Central Division, order of 10 November 2023, UPC_CFI_255/2023
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantITCiCo Spain S.L4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- Le juge rapporteur rejette la prorogation du délai de défense : signification valable malgré l'absence des pièces, difficultés d'accès et maladie non prouvées, demande tardive.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 796 333mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Seoul Viosys v expert e-Commerce (CFI, 20 January 2024) cited in this record
- Sanofi-Aventis Deutschland v Amgen (CoA, 13 October 2023) cited in this record
- Prinoth v Xelom (CFI, 16 April 2026) cites this decision
- TCL Europe v Corning (CFI, 8 September 2025) cites this decision
- Dai Nippon Printing v Zapp (CFI, 3 September 2025) cites this decision
- Meril Italy v Edwards Lifesciences (CFI, 28 February 2024) cites this decision
- Meril Italy v Edwards Lifesciences (CFI, ORD_10310/2024, 27 February 2024) cites this decision
- Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9062/2024, 20 February 2024) cites this decision
- Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9060/2024, 20 February 2024) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 796 333 | Mentioned in the analysis (role not qualified) Also mentioned in 4 other decision(s): Bayerische Motoren Werke v ITCiCo Spain (CFI, 16 September 2024) · Bayerische Motoren Werke v ITCiCo Spain (CFI, 31 March 2025) · ITCiCo Spain v Bayerische Motoren Werke (CFI, 9 January 2025) · ITCiCo Spain v Bayerische Motoren Werke (CFI, 29 April 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.